COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 490: Articles 4891-4900  | Next

Impact of COVID-19 pandemic on the etiology and characteristics of community-acquired pneumonia among children requiring bronchoalveolar lavage in northern China
Liu, R., Zhang, Y., Lu, Z., Shen, C., Wang, J., Zhao, Q., Hou, T., Niu, F., Kong, Q., Ning, J., Yang, L.
10.1101/2023.03.02.23286686 — Posted: 2023-03-05
Bivalent booster effectiveness against severe COVID-19 outcomes in Finland, September 2022 - January 2023
Poukka, E., Goebeler, S., Nohynek, H., Leino, T., Baum, U.
10.1101/2023.03.02.23286561 — Posted: 2023-03-05
Molnupiravir's real-world effectiveness in COVID-19 non-hospitalized patients at high risk of severe disease: a single-center study
Gmizic, I., Todorovic, N., Sabanovic, M., Kekic, N., Boskovic, N., Milosevic, I., Stevanovic, G.
10.1101/2023.03.03.23286761 — Posted: 2023-03-05
Third and fourth vaccine doses broaden and prolong immunity to SARS-CoV-2 in immunocompromised adult patients
Cheung, M. W., Dayam, R. M., Shapiro, J. R., Law, J. C., Chao, G. Y., Pereira, D., Goetgebuer, R. L., Croitoru, D., Stempak, J. M., Acheampong, L., Rizwan, S., Lee, J. D., Jacob, L., Ganatra, D., Law, R., Rodriguez Castellanos, V. E., Kern-Smith, M., Delgado-Brand, M., Mailhot, G., Haroon, N., Inman, R. D., Piguet, V., Chandran, V., Silverberg, M. S., Watts, T. H., Gingras, A.-C.
10.1101/2023.03.01.23286513 — Posted: 2023-03-05
Association of Nirmatrelvir/Ritonavir Treatment with Long COVID Symptoms in an Online Cohort of Non-Hospitalized Individuals Experiencing Breakthrough SARS-CoV-2 Infection in the Omicron Era
Durstenfeld, M. S., Peluso, M. J., Lin, F., Peyser, N. D., Isasi, C., Carton, T. W., Henrich, T. J., Deeks, S. G., Olgin, J. E., Pletcher, M. J., Beatty, A. L., Marcus, G. M., Hsue, P. Y.
10.1101/2023.03.02.23286730 — Posted: 2023-03-05
Campus Sewage Water Surveillance based dynamics and infection trends of SARS-CoV-2 variants during third wave of COVID-19 in Pune, India
Dharne, M.
10.1101/2023.03.02.23286683 — Posted: 2023-03-05
Detection of SARS-CoV-2 in Schools Using Built Environment Testing in Ottawa, Canada: A Multi-Facility Prospective Surveillance Study
Thampi, N., Burhunduli, T., Strain, J., Raudanskis, A., Moggridge, J. A., Hinz, A., Doukhanine, E., Castellani, L., Fralick, M., Kassen, R., McCready, J., Nott, C., Wong, A., MacFadden, D. R.
10.1101/2023.03.03.23286750 — Posted: 2023-03-05
Decline in prevalence of tuberculosis following an intensive case-finding campaign and the COVID-19 pandemic in an urban Ugandan community
Kendall, E. A., Kitonsa, P. J., Nalutaaya, A., Robsky, K. O., Erisa, K. C., Mukiibi, J., Cattamanchi, A., Kato-Maeda, M., Katamba, A., Dowdy, D. W.
10.1101/2023.03.03.23286745 — Posted: 2023-03-05
Phenome-wide association study to explore the long-term symptoms after infection with novel coronavirus in the UK Biobank
Zhang, K., Liu, X., Fu, P., Zhao, Y., Yu, Q., Liu, S., Xue, F.
10.1101/2023.03.03.23286122 — Posted: 2023-03-05
Residual Sanitization of Three Human Respiratory Viruses on a Hard, Non-Porous Surface
Ikner, L. A., Rabe, A. B., Gerba, C. P.
10.1101/2023.03.02.530883 — Posted: 2023-03-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).